GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannovum Cannabis AG (XTER:27N0) » Definitions » EBITDA Margin %

Cannovum Cannabis AG (XTER:27N0) EBITDA Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Cannovum Cannabis AG EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Cannovum Cannabis AG's EBITDA for the six months ended in Jun. 2024 was €-0.07 Mil. Cannovum Cannabis AG's Revenue for the six months ended in Jun. 2024 was €0.00 Mil. Therefore, Cannovum Cannabis AG's EBITDA margin for the quarter that ended in Jun. 2024 was 0.00%.


Cannovum Cannabis AG EBITDA Margin % Historical Data

The historical data trend for Cannovum Cannabis AG's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannovum Cannabis AG EBITDA Margin % Chart

Cannovum Cannabis AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
-516.67 -2,700.00 - -1,575.00

Cannovum Cannabis AG Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only - - - -75,800.00 -

Competitive Comparison of Cannovum Cannabis AG's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannovum Cannabis AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannovum Cannabis AG's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannovum Cannabis AG's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Cannovum Cannabis AG's EBITDA Margin % falls into.


;
;

Cannovum Cannabis AG EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Cannovum Cannabis AG's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.063/0.004
=-1,575.00 %

Cannovum Cannabis AG's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-0.07/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannovum Cannabis AG  (XTER:27N0) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Cannovum Cannabis AG EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Cannovum Cannabis AG's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannovum Cannabis AG Business Description

Traded in Other Exchanges
Address
Rheinsberger Street 76/77, Berlin, BB, DEU, 10115
Cannovum Cannabis AG is a fully licensed pharmaceutical wholesaler, importer, and manufacturer of high-quality medical cannabis products based in Berlin. It focuses on the import of medical cannabis, medical-scientific education, and distribution for facilitated access to cannabis-based therapies.

Cannovum Cannabis AG Headlines

No Headlines